HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clarins’ myBlend Line Gives Personalized Attention To Evolving Skin Needs

This article was originally published in The Rose Sheet

Executive Summary

Clarins is launching myBlend, a new skin-care brand that addresses a woman's evolving skin-care needs with nuanced, "highly personalized" treatments, the firm announces

You may also be interested in...



Marketing In Brief

Living Proof: No Frizz hair-care line is first launch from company led by biomedical scientist and MIT institute professor Robert Langer, that aims to outperform - rather than out-market - the personal-care competition. "We saw most of the industry using the same basic ingredients and spending millions to try to differentiate their largely similar products," says Joe Flint of founding firm Polaris Venture Partners. Living Proof's "point of difference is to approach beauty problems from an outsider's perspective, using the resources you would typically find in a venture-backed bio-pharma startup," with guidance from personal-care industry veterans but no "preconceived notions of what could and could not be done," according to Oct. 7 release from Cambridge, Mass. company. No Frizz hair products feature new molecule PolyflouroEster, which is smaller than traditional frizz-fighting agents and offers an extremely thin humidity barrier while reducing surface friction, making it the most effective, lightweight frizz-fighter on market today, Living Proof asserts. National Medal of Science winner Langer - whose research, firm notes, has led to breakthroughs in advanced drug delivery - states: "Our thinking is that if we can find solutions for some of the toughest medical challenges, we should certainly be able to cure frizz.

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel